There are so many ASX shares Aussies can buy, as share prices fluctuate constantly. Some can end up being significantly undervalued, based on analyst opinions.

Company updates can change investor confidence , while sell-offs can unlock ideas for opportunistic Aussies.

Analysts regularly tells investors about price targets, which explains to us where the share price could be in 12 months from the time of that investment call.

Let’s look at two ASX shares with a potentially exciting future.

Judo Capital Holdings Ltd (ASX: JDO)

Judo is a financial institution that provides loans to small and medium enterprises (SMEs), with term deposits being a key source of funding. Term deposit customers include SMSFs, individuals and businesses.

The company recently said its FY26 cost-to-risk is expected to be in the range of between $116 million to $122 million because of three exposures across different sectors as a result of customer-specific developments.

Even so, Judo still expects its FY26 profit before tax (PBT) to be between $163 million to $169 million, or approximately 30% growth compared to FY25.

The company also expects FY27 PBT to be between $210 million to $220 million, which would be a 30% rise as a result of growth and operating leverage despite this period of uncertainty.

According to CMC Invest, there have been 10 ratings on the business within the last three months, with eight of those being a buy and two being a hold. Of those 10 ratings, the average price target is $1.63, which implies a possible rise of 77% from where it is at the time of writing.                                                                         

Nextdc Ltd (ASX: NXT)

Another ASX share that has attracted a lot of positive attention is Nextdc, a business that builds, owns and operates data centres in a number of Australian cities. It also has a growing number of locations overseas, including Japan, Malaysia and New Zealand.

The business is investing heavily in data centres to provide the computing infrastructure feeding global demand for AI.

Nextdc is seeing this period as a great time to heavily invest, and it’s also seeing a rapid increase in the contracted utilisation. In mid-April, the company upgraded its contracted utilisation by 60% to 667MW and it also upgraded its FY26 capital expenditure guidance range to between $2.7 billion to $3 billion.

According to CMC Invest, there have been eight broker ratings on the business in the last three months, with all of those being a buy. The average price target of those eight analysts is $20.41, which implies a possible rise of 46%.

These are both businesses growing profit rapidly, though there are other ASX shares that could be even better buys.

The post 2 ASX shares tipped to grow 45% or more in the next 12 months appeared first on The Motley Fool Australia.

More reading

• SK Hynix IPOs in the US. Here’s what that means for ASX investors
• NEXTDC boosts funding with $2.3 billion senior debt facility upsize
• 9 ASX 200 shares downgraded by analysts this week
• 3 ASX 200 shares with 50% to 100% upside in FY27
• Buy, hold, sell: CAR Group, Judo Capital, and Worley shares

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX tech shares spent the early 2020s being described as the future of the local share market.

The scoreboard tells a different story.

The Betashares S&P/ASX Australian Technology ETF (ASX: ATEC), which tracks the S&P/ASX All Technology Index (ASX: XTX), traded at $22.37 five years ago.

Today it trades at approximately $22.69.

A $10,000 investment five years ago would have bought approximately 447 units.

Those 447 units are worth approximately $10,143 today.

That is a capital gain of roughly 1.4% over five full years, before distributions.

Distributions would add modestly to that figure, but the headline is unavoidable: on price alone, ASX tech investors have gone almost nowhere.

How ASX tech shares went nowhere so dramatically

The flat five-year result conceals extraordinary volatility.

ATEC returned 3.89% in 2021, then crashed 32.43% in 2022 as interest rates rose and growth valuations compressed violently.

It then recovered hard, gaining 34.91% in 2023 and 42.27% in 2024, before falling 10.60% in 2025 and dropping a further 12% so far in 2026.

The ETF now sits approximately 30% below its twelve-month high of $33.29.

Investors who bought and sold at the right moments in that cycle did extremely well.

Investors who simply held for five years captured none of it.

Here are some ASX tech shares that have defined the performance of this ETF over the last 5 years.

Xero a great business, a terrible entry price

Xero Ltd (ASX: XRO) is one of ATEC’s largest holdings at approximately 9% of the fund.

Xero has fallen approximately 60% from its all-time high of $196.52.

The business itself has not deteriorated.

The FY2026 result delivered 31% revenue growth to $2.75 billion, with the US business surging 240% on the back of the Melio acquisition.

The decline is almost entirely a valuation story. At its peak, Xero traded at well over 100 times earnings. This multiple assumed years of uninterrupted growth and left no margin for the rate environment to change.

WiseTech Global: the index’s biggest destroyer of value

WiseTech Global Ltd (ASX: WTC) sits at approximately 5.7% of ATEC.

WiseTech was the worst performer in the entire ASX 200 in FY26, dropping 70% in value.

Unlike Xero, WiseTech’s collapse was not primarily about valuation.

It was about governance, driven by a series of allegations against founder Richard White, including an AFP investigation.

However, the CargoWise platform remains used by 23 of the world’s top 25 global freight forwarders, and WiseTech has maintained its FY26 guidance throughout the turmoil.

The business did not break, rather, investor trust did.

What this actually teaches investors

The lesson here is not “avoid technology.”

It is that entry valuation determines outcomes, and that concentration inside a narrow sector index can be punishing.

ATEC’s top ten holdings account for approximately 75% of the fund.

When two of the largest fall 60% and 70% respectively, nothing in the remaining holdings can offset that.

Over the same five-year window, an investor in a broader ASX 200 index fund would have collected years of dividends and franking credits while the tech index went sideways.

Foolish takeaway for ASX tech shares

$10,000 invested in ASX tech shares five years ago is worth approximately $10,143 today on a capital basis.

The businesses inside that index include some of the finest companies in Australia.

The prices investors paid for them in 2021 were the problem, not the businesses themselves.

For investors looking at today’s heavily discounted tech sector, that fact is worth considering.

The post Here’s what $10,000 invested in ASX tech shares 5 years ago would be worth now appeared first on The Motley Fool Australia.

More reading

• 3 ASX ETFs with strong long-term growth potential
• Another CEO share sale has this ASX 100 tech stock sinking today
• Should I invest $2,500 into WiseTech shares?
• 10 fantastic ASX shares to buy for FY27
• Has the WiseTech share price finally hit the bottom after crashing 50%?

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When it comes to looking for outsized returns among ASX shares, it pays to check in with the professionals.

I’ve reviewed the reports coming out of the major broking houses and zeroed in on four from Canaccord Genuity, which profile companies that could do very well indeed.

Let’s see which companies they like at the moment.

Bravura Solutions Ltd (ASX: BVS)

Shares in Bravura jumped last week after the company delivered a better-than-expected earnings update for the past financial year.

The company said revenue would be within its previously guided range of $280 to $285 million, but cash EBITDA would be about $77 million, compared with previous guidance of $69 to $73 million.

Managing Director Colin Greenhill said the company had “continued to manage costs well whilst investing in core technology and exploring new initiatives”.

Canaccord Genuity said in its note to clients they believed cost management was the key to the result.

They said:

With costs very tightly managed in the half, we believe this positions BVS well entering FY27. With the new financial year potentially having lower project work, in our view, given FY26 featured work on the Aware and Telstra Super merger (of which Aware has labelled as completed), the potential for lower FY27 project revenue seems to be well managed by the cost-base being tightly managed.

The broker has a $2.73 price target on Bravura shares compared to $2.17 at the time of writing.

Light & Wonder Inc (ASX: LNW)

Canaccord Genuity said a recent share price pullback has Light & Wonder shares trading near 12-month lows, “and offering valuation constructs not seen in recent years”.

They added:

In addition, a widening of the discount to Aristocrat Leisure (ASX: ALL) has been apparent in recent months at levels not far from historic peaks. We remain attracted to the LNW thesis and consider the business to have a solid medium-term growth profile.

The broker has a $182 price target on Light & Wonder shares compared to $102.78 at the time of writing.

Mesoblast Ltd (ASX: MSB)

This drug company recently reported its quarterly sales results for its flagship drug Ryoncil, notching up US$36 million for the quarter and US$115 million for the full year.

The company’s Chief Executive Officer, Dr Silviu Itescu, said Mesoblast was anticipating continued revenue growth in the current financial year, “in line with momentum we are seeing across major U.S. paediatric centres”.

Canaccord Genuity said it viewed consensus estimates of US$180 to US$190 million in Ryoncil sales this year as ambitious, but still has a bullish share price target of $3.23, up from $2.34 at the time of writing.

Pantoro Gold Ltd (ASX: PNR)

Canaccord Genuity has a very bullish $4.20 share price target on this company, compared to the price of $2.04 at the time of writing, but stresses that this is a speculative buy for investors.

Pantoro missed production estimates for the June quarter, but Canaccord said the longer-term story was of interest.

PNR expects to release its 5-year production plan this quarter alongside its annual Resource and Reserve update, which we expect will incorporate the new high-grade underground zones being delineated by PNR’s extensive ongoing growth program. We note PNR has reaffirmed its long-term growth target of up to 200kozpa of production.

This compares to the current guidance for FY27 of 90,000 to 105,000 ounces of gold.

The post 4 ASX shares which could improve by 25% to more than 100% appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Here are the top 10 ASX 200 shares today
• Why Mesoblast shares could double in value
• 5 things to watch on the ASX 200 on Monday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bravura Solutions and Light & Wonder Inc. The Motley Fool Australia has recommended Light & Wonder Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.